Musculoskeletal Disorder Stem Cell Therapy Market - Global Outlook and Forecast 2022-2028

March 2022 | 68 pages | ID: MCED2EBDE853EN
Market Monitor Global

Abstracts

Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. This report studies on the Musculoskeletal Disorder Stem Cell Therapy.

This report contains market size and forecasts of Musculoskeletal Disorder Stem Cell Therapy in Global, including the following market information:

Global Musculoskeletal Disorder Stem Cell Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Musculoskeletal Disorder Stem Cell Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Allogeneic Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Musculoskeletal Disorder Stem Cell Therapy include Osiris Therapeutics, NuVasive, Takeda (TiGenix) and Medi-post, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Musculoskeletal Disorder Stem Cell Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Musculoskeletal Disorder Stem Cell Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Musculoskeletal Disorder Stem Cell Therapy Market Segment Percentages, by Type, 2021 (%)

• Allogeneic
• Autologous

Global Musculoskeletal Disorder Stem Cell Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Musculoskeletal Disorder Stem Cell Therapy Market Segment Percentages, by Application, 2021 (%)

• Muscle disease
• Skeletal disease

Global Musculoskeletal Disorder Stem Cell Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Musculoskeletal Disorder Stem Cell Therapy Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Musculoskeletal Disorder Stem Cell Therapy revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Musculoskeletal Disorder Stem Cell Therapy revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Osiris Therapeutics
• NuVasive
• Takeda (TiGenix)
• Medi-post

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Musculoskeletal Disorder Stem Cell Therapy Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Musculoskeletal Disorder Stem Cell Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL MUSCULOSKELETAL DISORDER STEM CELL THERAPY OVERALL MARKET SIZE

2.1 Global Musculoskeletal Disorder Stem Cell Therapy Market Size: 2021 VS 2028
2.2 Global Musculoskeletal Disorder Stem Cell Therapy Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Musculoskeletal Disorder Stem Cell Therapy Players in Global Market
3.2 Top Global Musculoskeletal Disorder Stem Cell Therapy Companies Ranked by Revenue
3.3 Global Musculoskeletal Disorder Stem Cell Therapy Revenue by Companies
3.4 Top 3 and Top 5 Musculoskeletal Disorder Stem Cell Therapy Companies in Global Market, by Revenue in 2021
3.5 Global Companies Musculoskeletal Disorder Stem Cell Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Musculoskeletal Disorder Stem Cell Therapy Players in Global Market
  3.6.1 List of Global Tier 1 Musculoskeletal Disorder Stem Cell Therapy Companies
  3.6.2 List of Global Tier 2 and Tier 3 Musculoskeletal Disorder Stem Cell Therapy Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Musculoskeletal Disorder Stem Cell Therapy Market Size Markets, 2021 & 2028
  4.1.2 Allogeneic
  4.1.3 Autologous
4.2 By Type - Global Musculoskeletal Disorder Stem Cell Therapy Revenue & Forecasts
  4.2.1 By Type - Global Musculoskeletal Disorder Stem Cell Therapy Revenue, 2017-2022
  4.2.2 By Type - Global Musculoskeletal Disorder Stem Cell Therapy Revenue, 2023-2028
  4.2.3 By Type - Global Musculoskeletal Disorder Stem Cell Therapy Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Musculoskeletal Disorder Stem Cell Therapy Market Size, 2021 & 2028
  5.1.2 Muscle disease
  5.1.3 Skeletal disease
5.2 By Application - Global Musculoskeletal Disorder Stem Cell Therapy Revenue & Forecasts
  5.2.1 By Application - Global Musculoskeletal Disorder Stem Cell Therapy Revenue, 2017-2022
  5.2.2 By Application - Global Musculoskeletal Disorder Stem Cell Therapy Revenue, 2023-2028
  5.2.3 By Application - Global Musculoskeletal Disorder Stem Cell Therapy Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Musculoskeletal Disorder Stem Cell Therapy Market Size, 2021 & 2028
6.2 By Region - Global Musculoskeletal Disorder Stem Cell Therapy Revenue & Forecasts
  6.2.1 By Region - Global Musculoskeletal Disorder Stem Cell Therapy Revenue, 2017-2022
  6.2.2 By Region - Global Musculoskeletal Disorder Stem Cell Therapy Revenue, 2023-2028
  6.2.3 By Region - Global Musculoskeletal Disorder Stem Cell Therapy Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Musculoskeletal Disorder Stem Cell Therapy Revenue, 2017-2028
  6.3.2 US Musculoskeletal Disorder Stem Cell Therapy Market Size, 2017-2028
  6.3.3 Canada Musculoskeletal Disorder Stem Cell Therapy Market Size, 2017-2028
  6.3.4 Mexico Musculoskeletal Disorder Stem Cell Therapy Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Musculoskeletal Disorder Stem Cell Therapy Revenue, 2017-2028
  6.4.2 Germany Musculoskeletal Disorder Stem Cell Therapy Market Size, 2017-2028
  6.4.3 France Musculoskeletal Disorder Stem Cell Therapy Market Size, 2017-2028
  6.4.4 U.K. Musculoskeletal Disorder Stem Cell Therapy Market Size, 2017-2028
  6.4.5 Italy Musculoskeletal Disorder Stem Cell Therapy Market Size, 2017-2028
  6.4.6 Russia Musculoskeletal Disorder Stem Cell Therapy Market Size, 2017-2028
  6.4.7 Nordic Countries Musculoskeletal Disorder Stem Cell Therapy Market Size, 2017-2028
  6.4.8 Benelux Musculoskeletal Disorder Stem Cell Therapy Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Musculoskeletal Disorder Stem Cell Therapy Revenue, 2017-2028
  6.5.2 China Musculoskeletal Disorder Stem Cell Therapy Market Size, 2017-2028
  6.5.3 Japan Musculoskeletal Disorder Stem Cell Therapy Market Size, 2017-2028
  6.5.4 South Korea Musculoskeletal Disorder Stem Cell Therapy Market Size, 2017-2028
  6.5.5 Southeast Asia Musculoskeletal Disorder Stem Cell Therapy Market Size, 2017-2028
  6.5.6 India Musculoskeletal Disorder Stem Cell Therapy Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Musculoskeletal Disorder Stem Cell Therapy Revenue, 2017-2028
  6.6.2 Brazil Musculoskeletal Disorder Stem Cell Therapy Market Size, 2017-2028
  6.6.3 Argentina Musculoskeletal Disorder Stem Cell Therapy Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Musculoskeletal Disorder Stem Cell Therapy Revenue, 2017-2028
  6.7.2 Turkey Musculoskeletal Disorder Stem Cell Therapy Market Size, 2017-2028
  6.7.3 Israel Musculoskeletal Disorder Stem Cell Therapy Market Size, 2017-2028
  6.7.4 Saudi Arabia Musculoskeletal Disorder Stem Cell Therapy Market Size, 2017-2028
  6.7.5 UAE Musculoskeletal Disorder Stem Cell Therapy Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Osiris Therapeutics
  7.1.1 Osiris Therapeutics Corporate Summary
  7.1.2 Osiris Therapeutics Business Overview
  7.1.3 Osiris Therapeutics Musculoskeletal Disorder Stem Cell Therapy Major Product Offerings
  7.1.4 Osiris Therapeutics Musculoskeletal Disorder Stem Cell Therapy Revenue in Global Market (2017-2022)
  7.1.5 Osiris Therapeutics Key News
7.2 NuVasive
  7.2.1 NuVasive Corporate Summary
  7.2.2 NuVasive Business Overview
  7.2.3 NuVasive Musculoskeletal Disorder Stem Cell Therapy Major Product Offerings
  7.2.4 NuVasive Musculoskeletal Disorder Stem Cell Therapy Revenue in Global Market (2017-2022)
  7.2.5 NuVasive Key News
7.3 Takeda (TiGenix)
  7.3.1 Takeda (TiGenix) Corporate Summary
  7.3.2 Takeda (TiGenix) Business Overview
  7.3.3 Takeda (TiGenix) Musculoskeletal Disorder Stem Cell Therapy Major Product Offerings
  7.3.4 Takeda (TiGenix) Musculoskeletal Disorder Stem Cell Therapy Revenue in Global Market (2017-2022)
  7.3.5 Takeda (TiGenix) Key News
7.4 Medi-post
  7.4.1 Medi-post Corporate Summary
  7.4.2 Medi-post Business Overview
  7.4.3 Medi-post Musculoskeletal Disorder Stem Cell Therapy Major Product Offerings
  7.4.4 Medi-post Musculoskeletal Disorder Stem Cell Therapy Revenue in Global Market (2017-2022)
  7.4.5 Medi-post Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Musculoskeletal Disorder Stem Cell Therapy Market Opportunities & Trends in Global Market
Table 2. Musculoskeletal Disorder Stem Cell Therapy Market Drivers in Global Market
Table 3. Musculoskeletal Disorder Stem Cell Therapy Market Restraints in Global Market
Table 4. Key Players of Musculoskeletal Disorder Stem Cell Therapy in Global Market
Table 5. Top Musculoskeletal Disorder Stem Cell Therapy Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Musculoskeletal Disorder Stem Cell Therapy Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Musculoskeletal Disorder Stem Cell Therapy Revenue Share by Companies, 2017-2022
Table 8. Global Companies Musculoskeletal Disorder Stem Cell Therapy Product Type
Table 9. List of Global Tier 1 Musculoskeletal Disorder Stem Cell Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Musculoskeletal Disorder Stem Cell Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Musculoskeletal Disorder Stem Cell Therapy Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Musculoskeletal Disorder Stem Cell Therapy Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Musculoskeletal Disorder Stem Cell Therapy Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Musculoskeletal Disorder Stem Cell Therapy Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Musculoskeletal Disorder Stem Cell Therapy Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Musculoskeletal Disorder Stem Cell Therapy Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Musculoskeletal Disorder Stem Cell Therapy Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Musculoskeletal Disorder Stem Cell Therapy Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Musculoskeletal Disorder Stem Cell Therapy Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Musculoskeletal Disorder Stem Cell Therapy Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Musculoskeletal Disorder Stem Cell Therapy Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Musculoskeletal Disorder Stem Cell Therapy Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Musculoskeletal Disorder Stem Cell Therapy Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Musculoskeletal Disorder Stem Cell Therapy Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Musculoskeletal Disorder Stem Cell Therapy Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Musculoskeletal Disorder Stem Cell Therapy Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Musculoskeletal Disorder Stem Cell Therapy Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Musculoskeletal Disorder Stem Cell Therapy Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Musculoskeletal Disorder Stem Cell Therapy Revenue, (US$, Mn), 2023-2028
Table 30. Osiris Therapeutics Corporate Summary
Table 31. Osiris Therapeutics Musculoskeletal Disorder Stem Cell Therapy Product Offerings
Table 32. Osiris Therapeutics Musculoskeletal Disorder Stem Cell Therapy Revenue (US$, Mn), (2017-2022)
Table 33. NuVasive Corporate Summary
Table 34. NuVasive Musculoskeletal Disorder Stem Cell Therapy Product Offerings
Table 35. NuVasive Musculoskeletal Disorder Stem Cell Therapy Revenue (US$, Mn), (2017-2022)
Table 36. Takeda (TiGenix) Corporate Summary
Table 37. Takeda (TiGenix) Musculoskeletal Disorder Stem Cell Therapy Product Offerings
Table 38. Takeda (TiGenix) Musculoskeletal Disorder Stem Cell Therapy Revenue (US$, Mn), (2017-2022)
Table 39. Medi-post Corporate Summary
Table 40. Medi-post Musculoskeletal Disorder Stem Cell Therapy Product Offerings
Table 41. Medi-post Musculoskeletal Disorder Stem Cell Therapy Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Musculoskeletal Disorder Stem Cell Therapy Segment by Type in 2021
Figure 2. Musculoskeletal Disorder Stem Cell Therapy Segment by Application in 2021
Figure 3. Global Musculoskeletal Disorder Stem Cell Therapy Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Musculoskeletal Disorder Stem Cell Therapy Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Musculoskeletal Disorder Stem Cell Therapy Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Musculoskeletal Disorder Stem Cell Therapy Revenue in 2021
Figure 8. By Type - Global Musculoskeletal Disorder Stem Cell Therapy Revenue Market Share, 2017-2028
Figure 9. By Application - Global Musculoskeletal Disorder Stem Cell Therapy Revenue Market Share, 2017-2028
Figure 10. By Region - Global Musculoskeletal Disorder Stem Cell Therapy Revenue Market Share, 2017-2028
Figure 11. By Country - North America Musculoskeletal Disorder Stem Cell Therapy Revenue Market Share, 2017-2028
Figure 12. US Musculoskeletal Disorder Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Musculoskeletal Disorder Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Musculoskeletal Disorder Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Musculoskeletal Disorder Stem Cell Therapy Revenue Market Share, 2017-2028
Figure 16. Germany Musculoskeletal Disorder Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 17. France Musculoskeletal Disorder Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Musculoskeletal Disorder Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Musculoskeletal Disorder Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Musculoskeletal Disorder Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Musculoskeletal Disorder Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Musculoskeletal Disorder Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Musculoskeletal Disorder Stem Cell Therapy Revenue Market Share, 2017-2028
Figure 24. China Musculoskeletal Disorder Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Musculoskeletal Disorder Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Musculoskeletal Disorder Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Musculoskeletal Disorder Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 28. India Musculoskeletal Disorder Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Musculoskeletal Disorder Stem Cell Therapy Revenue Market Share, 2017-2028
Figure 30. Brazil Musculoskeletal Disorder Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Musculoskeletal Disorder Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Musculoskeletal Disorder Stem Cell Therapy Revenue Market Share, 2017-2028
Figure 33. Turkey Musculoskeletal Disorder Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Musculoskeletal Disorder Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Musculoskeletal Disorder Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Musculoskeletal Disorder Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 37. Osiris Therapeutics Musculoskeletal Disorder Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. NuVasive Musculoskeletal Disorder Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Takeda (TiGenix) Musculoskeletal Disorder Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Medi-post Musculoskeletal Disorder Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)